REvaSCUlarization StratEgy of Multivessel Coronary Artery Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic SHOCK Undergoing Veno-arterial Extracorporeal Membrane Oxygenator: Randomized-Controlled Trial (RESCUE-SHOCK)
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Phase 4
SUMMARY
This study is a prospective, open-label, two-arm, randomized multicenter trial to identify whether immediate multi-vessel PCI would be better in clinical outcomes compared with culprit lesion-only PCI for AMI and multi-vessel disease with an advanced form of CS patients who require veno-arterial extracorporeal membrane oxygenator (VA-ECMO).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Subject must be at least 19 years of age
• Patients presented with AMI (ST-segment elevation MI \[STEMI\] or non-ST-segment elevation MI \[NSTEMI\]) complicated by CS (SCAI Shock classification C, D or E) who requiring VA-ECMO.
• Target lesions amenable for planned primary PCI by operators' decision
• Patients with multi-vessel disease
Locations
Other Locations
Republic of Korea
Samsung Medical Center
RECRUITING
Seoul
Contact Information
Primary
Jeong Hoon Yang, MD
jhysmc@gmail.com
82-2-3410-3419
Backup
Ki Hong Choi, MD
cardiokh@gmail.com
82-2-3410-6653
Time Frame
Start Date: 2022-11-16
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 560
Treatments
Active_comparator: Culprit-lesion only PCI arm
Patients will receive culprit-lesion only PCI.
Experimental: Immediate multi-vesesl PCI arm
Patients will receive immediate multi-vessel PCI.
Related Therapeutic Areas
Sponsors
Leads: Samsung Medical Center